Related Experiment Video
Updated: Oct 19, 2026

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening
Published on: October 4, 2017
Nanotechnology-driven cryopreservation across cells and 3D constructs
Juhyun Kim1, Yeonwoo Jang1, Hansoo Park1
1School of Integrative Engineering, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul, 06974, Republic of Korea.
Abstract:
Cryopreservation is essential for cell-based research, regenerative medicine, and emerging therapies; however, conventional strategies remain limited by ice-induced damage, osmotic imbalance, and cryoprotectant (CPA)-associated toxicity. This review discusses the mechanisms of cryoinjury, limitations of conventional CPA-based strategies, and emerging approaches, including combinatorial CPA formulations and ice-modulating agents such as antifreeze proteins and synthetic ice recrystallization inhibitors. Building on these advances, we evaluate nanotechnology-enabled platforms for precise and multifunctional cryoprotection, encompassing nanocarrier-mediated intracellular CPA delivery, nanomaterial-based extracellular ice modulation, and uniform volumetric rewarming. We further discuss the challenges and emerging nanotechnology-enabled strategies for preserving three-dimensional cellular constructs, including spheroids and organoids, where diffusion limitations, spatial heterogeneity, and structural complexity require tailored preservation approaches. Together, these advances establish nanotechnology as an integrated platform for next-generation cryopreservation by enabling coordinated control of CPA delivery, ice behavior, and rewarming in regenerative medicine and cell-based therapeutics.

